Title: Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
13224-94-7
14048-30-7
14687-15-1
14168-65-1
16232-91-0
1825-00-9
56146-88-4 | 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-N[N-(benzyloxycarbonyl)-ε-aminocaproyl]-β-D-glucopyranosylamine | AA00DF8A | MFCD04973532
501120-38-3 | 4-[(2-Ethoxybenzoyl)amino]-1-methyl-5-propyl-1H-pyrazole-3-carboxamide | AA00DFDH | MFCD16619408
52363-14-1 | Acetic acid, (cyclopentylthio)- (9CI) | AA00DFJ8 | MFCD07364147
51334-85-1 | (4-METHYLPHENYL)-1-(2H)-PHTHALAZINONE | AA00DFXA | MFCD00222976
55076-32-9 | Methyl 3-hydroxy-5-nitrobenzoate | AA00DG5N | MFCD00463877
54623-24-4 | METHYL-A-L-ACOSAMINE | AA00DGP8 | MFCD09752102
54903-54-7 | 1-(4-Amino-3-hydroxyphenyl)ethanone | AA00DH6D | MFCD01727691
471909-65-6 | 3,5-Dichloropicolinaldehyde | AA00DHSJ | MFCD09839149
530080-17-2 | 1-Iodo-4-(2,2,2-trifluoroethoxy)benzene | AA00DHWH | MFCD08458086
4736-71-4 | Pyrrolidine-1-carboxylic acid amide | AA00DID8 | MFCD00509172